ANICCA-ClassII: A Phase II trial assessing nivolumab in stron class II expressing microsatellite stable colorectal cancer
STAR-TREC: An international, multi-centre, randomised, phase II feasibility study comprising a 1:1:1 randomisation for eligible subjects with a small, clinically localised rectal cancer.